Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|October 16, 2025
Preliminary Efficacy/Feasibility Study of a Breast Cancer-Related Lymphedema Prospective Screening and Early Intervention Program at the Dana-Farber Brigham Cancer CenterSara P Myers, Jacob M Jasper, Tessa Higgins, et al.
Annals of Surgical Oncology|January 18, 2022
How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort StudyAnna Weiss, Claire King, Samantha Grossmith, et al.
The Breast Journal|August 27, 2019
Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experienceFaina Nakhlis, Meredith M Regan, Yoon S Chun, et al.
Journal of Geriatric Oncology|May 28, 2019
Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancerMara A Schonberg, Rachel A Freedman, Abram R Recht, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 15, 2013
What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approachEren D Yeh, Heather A Jacene, Jennifer R Bellon, et al.
Breast Cancer Research and Treatment|January 22, 2020
Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patientsOluwadamilola M Fayanju, Yi Ren, Rachel A Greenup, et al.
Journal of Reconstructive Microsurgery|September 26, 2023
Preoperative Risk Factors for Lymphedema in Inflammatory Breast CancerLibby R Copeland-Halperin, Colby J Hyland, Goutam K Gadiraju, et al.
JAMA Network Open|April 9, 2026
Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast CancerJosé P Leone, Julieta Leone, Pietro De Placido, et al.
American Journal of Clinical Oncology|June 21, 2021
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast CancerKelly A Hirko, Meredith M Regan, Marie C Remolano, et al.
Clinical Breast Cancer|December 26, 2018
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor GradeHeather A Jacene, Trisha Youn, Pamela J DiPiro, et al.
Pageof 7